CancerWorld

A study on highly cited women scientists who have succeeded by conventional measures of academic achievement suggests that reaching the top does not mean that barriers have disappeared. For years, CancerWorld has documented the barriers that hold women back in…

After more than four decades under the leadership of Alberto Costa, the European School of Oncology enters a new chapter with Rossella Blasi as CEO. The transition brings together the legacy of Umberto Veronesi’s founding vision and the challenge of…

Science is moving at extraordinary speed. We can identify mutations once invisible, develop drugs that destroy proteins previously considered untouchable, and transform diagnoses that once offered little hope. Yet a patient can still wait too long for treatment. A brilliant…

When Brett Wilson finished cancer treatment at the age of 12, a hospital nurse walked outside with her and her mother and offered three words of advice: “Go be normal.” Wilson looked at her mother. “What does that mean? Go…

What children with cancer may be teaching us about medicine, uncertainty, and what it means to be human There are conversations in oncology that begin with a question. And then there are conversations in which, somewhere along the way, the…

In Tanzania in the early 2000s, healthcare for children with cancer was very limited. The majority of affected children never reached a treatment centre and 90% of those who did, ultimately died1. Today, childhood cancer care has been transformed with…

The history of pediatric oncology is one of extraordinary progress. Children who once had little chance of surviving cancer are now growing into adulthood, building careers, raising families and imagining futures that previous generations could not. But progress has also…

10 Years of PICI: From Discovery to Impact Ten years ago, the Parker Institute for Cancer Immunotherapy (PICI) was created around a bold premise: that progress in cancer research could be accelerated by changing not only what science pursued, but…

For many people with cancer in low- and middle-income countries (LMICs), the greatest barrier is not that treatment is unavailable. It is that the path to treatment is fragmented, difficult to navigate, and easy to fall out of. A person…

Emerging research suggests that understanding psychological wellbeing in people affected by cancer requires looking beyond traditional diagnostic categories. A cancer diagnosis is far more than a medical event. It can disrupt every aspect of a person's life, reshaping relationships, work,…